Enter to open, tab to navigate, enter to select
Valeant Pharmaceuticals International, Inc. tender offer for Obagi Medical Products, Inc.
| March 19, 2013 • Public Merger Agreements • $437.5 million (on date of amendment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.